Methods and compositions for treating melanoma
US-2024424002-A1 · Dec 26, 2024 · US
Prophylactic or therapeutic agent for cancer
US12357612B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12357612-B2 |
| Application number | US-202017442173-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 25, 2020 |
| Priority date | Mar 28, 2019 |
| Publication date | Jul 15, 2025 |
| Grant date | Jul 15, 2025 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
An object of the present invention is to provide a low molecular weight compound having a prophylactic or therapeutic action on cancer. A compound of the following formula (1), a compound of the following formula (2), or the like can be administered by a method such as oral administration to prevent or treat cancers such as colorectal cancer.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for treating cancer, comprising administering one or more compounds selected from the compound of the following formula (1-1), the compound of the following formula (2-1): or a pharmacologically acceptable salt thereof, to a subject in need of treatment of cancer. 2. The method according to claim 1 , wherein the cancer is a colorectal cancer. 3. The method according to claim 1 , wherein the one or more compounds are orally administered. 4. The method according to claim 2 , wherein the one or more compounds are orally administered.
Assignees
Inventors
Classifications
Mouth and digestive tract, i.e. intraoral and peroral administration · CPC title
- A61P35/00Primary
Antineoplastic agents · CPC title
for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants · CPC title
specific for leukemia · CPC title
- A61K31/405Primary
Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12357612B2 cover?
- An object of the present invention is to provide a low molecular weight compound having a prophylactic or therapeutic action on cancer. A compound of the following formula (1), a compound of the following formula (2), or the like can be administered by a method such as oral administration to prevent or treat cancers such as colorectal cancer.
- Who is the assignee on this patent?
- Univ Tohoku, Kake Educational Inst
- What technology area does this patent fall under?
- Primary CPC classification A61P35/00. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).